Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
11-Jul-2025 | 588 | 624.8 | 585.9 | 611.5 | 37,065 | 53,66,88,327.65 | 2,94,536 |
14-Jul-2025 | 611.5 | 619 | 602.2 | 612.45 | 13,776 | 16,80,20,810.75 | 1,01,536 |
15-Jul-2025 | 613 | 635 | 612 | 627.9 | 13,876 | 22,23,93,846.75 | 1,63,935 |
16-Jul-2025 | 630 | 631.3 | 615 | 616.95 | 8,706 | 9,67,06,791.2 | 77,268 |
17-Jul-2025 | 619 | 626 | 615.7 | 622.2 | 6,906 | 7,49,24,567.75 | 53,929 |
18-Jul-2025 | 623 | 626.8 | 615 | 624.35 | 8,519 | 10,34,05,359.65 | 87,550 |
21-Jul-2025 | 622 | 626.3 | 606.15 | 609.8 | 8,458 | 9,06,73,089.75 | 73,069 |
22-Jul-2025 | 611.05 | 622 | 605.6 | 616.3 | 8,267 | 8,04,74,084.2 | 55,788 |
23-Jul-2025 | 618 | 618 | 601.1 | 608.95 | 7,343 | 6,09,08,419.55 | 50,812 |
24-Jul-2025 | 649 | 705 | 643.65 | 678.85 | 1,65,298 | 5,30,43,06,376.2 | 15,95,915 |
25-Jul-2025 | 680 | 704 | 665.35 | 668.95 | 46,545 | 98,12,59,167.5 | 3,79,897 |
28-Jul-2025 | 675 | 679.5 | 630.3 | 643.35 | 39,786 | 60,84,99,831.2 | 4,18,060 |
29-Jul-2025 | 646 | 716.1 | 640.15 | 703.95 | 97,410 | 2,06,05,52,890.45 | 8,04,674 |
30-Jul-2025 | 709.8 | 719 | 687.2 | 697.45 | 29,903 | 54,35,93,565.3 | 2,29,060 |
31-Jul-2025 | 682 | 704 | 675 | 688.9 | 17,469 | 29,59,18,902.95 | 1,52,729 |
01-Aug-2025 | 689.1 | 694.35 | 660 | 665.35 | 18,019 | 22,55,13,866.05 | 1,31,393 |
04-Aug-2025 | 665.5 | 699.95 | 664.85 | 696.5 | 26,698 | 38,84,65,442 | 1,44,054 |
05-Aug-2025 | 696.5 | 704.1 | 670.55 | 676.3 | 14,878 | 17,63,75,972.2 | 94,363 |
06-Aug-2025 | 671.95 | 679 | 641 | 647.1 | 20,173 | 25,33,62,479.9 | 1,57,140 |
07-Aug-2025 | 642 | 671 | 640 | 667.55 | 14,716 | 18,41,31,923.55 | 1,04,970 |
08-Aug-2025 | 672 | 672 | 649.95 | 652.4 | 8,991 | 12,49,86,220.5 | 40,107 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
